Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma

20260 citationsJournal Articlegold Open Access

Authors

Julia Frimmel · University Hospital Schleswig-Holstein

Anke Morgner · Klinikum Chemnitz

Claudia Brogsitter · University Hospital Carl Gustav Carus

Karolin Trautmann-Grill · University Hospital Carl Gustav Carus

Desireé Kunadt · University Hospital Carl Gustav Carus

Raphael Teipel · University Hospital Carl Gustav Carus

Christoph Röllig

Abstract

In this small, selected cohort, haploidentical allogeneic HCT with individualized pre-treatment and conditioning regimens was associated with disease control in heavily pretreated patients with r/r MM.

Topics & Keywords

Multiple Myeloma Research and Treatments Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer Management and Research

Volume Volume 18, pp. 1-7

DOI: 10.2147/cmar.s564588

Field-Weighted Citation Impact: 0.00